China's Kangtai commences mid-stage trial of its experimental COVID-19 vaccine candidate

MLA

“China’s Kangtai Commences Mid-Stage Trial of Its Experimental COVID-19 Vaccine Candidate.” M2 Pharma, 29 Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.639778625&authtype=sso&custid=ns315887.

APA

China’s Kangtai commences mid-stage trial of its experimental COVID-19 vaccine candidate. (2020, October 29). M2 Pharma.

Chicago

M2 Pharma. 2020. “China’s Kangtai Commences Mid-Stage Trial of Its Experimental COVID-19 Vaccine Candidate,” October 29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.639778625&authtype=sso&custid=ns315887.